Where does Eikon Therapeutics, Inc.
's balance sheet data come from?

Question

Accepted Answer

Every line is extracted from Eikon Therapeutics, Inc.
's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q1 '25
Cash and cash equivalents	$161.15M+53.6%	$104.9M-48.7%	$204.58M—
Short-term investments	$351.03M+51.9%	$231.07M—	——
Total current assets	$529.5M+51.8%	$348.92M—	——
Property and equipment, net	$138.07M-3.4%	$142.9M—	——
Total assets	$850.83M+43.1%	$594.73M—	——
Accounts payable	$6.01M+782%	$681K-70.1%	$2.28M—
Total current liabilities	$45.06M-18.1%	$55.01M—	——
Total liabilities	$300.16M-3.9%	$312.3M—	——
Retained earnings	-$1B-9.0%	-$920.51M—	——
Total stockholders' equity	$550.67M+163%	-$879.03M-37.3%	-$640.14M-11.9%
Total liabilities and stockholders' equity	$850.83M+43.1%	$594.73M—	——

Eikon Therapeutics, Inc. EIKN Balance Sheet Statement

Questions, answered.